- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/15 - Oximes (C=N—O—)Hydrazines (N—N)Hydrazones (N—N=)
Patent holdings for IPC class A61K 31/15
Total number of patents in this class: 684
10-year publication summary
|
42
|
60
|
46
|
55
|
73
|
70
|
53
|
44
|
32
|
19
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Antecip Bioventures II LLC | 381 |
57 |
| Clexio Biosciences Ltd. | 100 |
21 |
| Vanda Pharmaceuticals, Inc. | 391 |
17 |
| Oklahoma Medical Research Foundation | 162 |
12 |
| The Regents of the University of California | 20868 |
10 |
| Hough Ear Institute | 28 |
10 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3295 |
9 |
| Centre National de La Recherche Scientifique | 11092 |
6 |
| The Trustees of the University of Pennsylvania | 4435 |
6 |
| Kyushu University, National University Corporation | 1733 |
6 |
| Highlight Therapeutics S.L. | 19 |
6 |
| Bristol-myers Squibb Company | 4757 |
5 |
| Dow Global Technologies LLC | 11029 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2671 |
5 |
| Emory University | 1724 |
5 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3325 |
5 |
| Institut Gustave Roussy | 267 |
5 |
| Nippon Chemiphar Co., Ltd. | 225 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3016 |
5 |
| Université Paris-saclay | 640 |
5 |
| Other owners | 479 |